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HIV Testing in the 
United States
HIV testing is essential for improving the health of people living with HIV and helping to prevent new infections.  
CDC estimates that 18 percent of people infected with HIV in the United States are unaware of their infection – more than 
200,000 people.1 CDC also estimates that approximately half of the estimated 50,000 new HIV infections each year are 
transmitted by people who do not know that they are HIV-positive.2,3 
CDC recommends that all adolescents and adults get 
tested at least once for HIV as a routine part of medical 
care, and that gay and bisexual men and others at 
high risk be tested more frequently. CDC is working to 
increase testing among people at higher risk in a wide 
range of settings outside of the medical system.
Benefits of Knowing your  
HIV Status
HIV testing has never been quicker or easier than it is 
today – and it has significant benefits for individuals who 
are HIV positive and for those who test negative.
For those who have HIV, testing is the gateway to 
treatment and care. Highly effective treatments make 
it possible to live a long, healthy life with HIV. However, 
one-third of people learn they are infected with HIV less 
than a year before being diagnosed with AIDS, meaning 
they have already been infected for many years and may 
not fully benefit from treatment.4
Testing also helps reduce the spread of HIV.  Early 
diagnosis allows those infected to take steps to protect
their partners from infection, and early treatment can 
lower viral load, and reduce the risk of transmitting HIV 
to others by 96 percent.5
And, for people who do not have HIV, testing is just as 
critical because this information can help link them  
with important prevention services so they can remain 
HIV-free.  
Following are three types of HIV tests. If the first test is positive, a follow-up test is 
necessary to validate the result.
n A ntibody Test: Detects the presence of antibodies against HIV, which typically develop within two to eight 
weeks after exposure to the virus.  An antibody test can be conducted on a sample of blood or oral fluid.  
n C ombination Antigen-Antibody Test: Detects both the antibody to HIV and the antigen “p24” – a protein that 
is part of the virus itself.  Because the p24 antigen can be detected within four to seven days before antibodies 
appear – combination tests can also identify very early infections. 
n RNA T est: Detects the presence of the virus in the blood.  An RNA test can detect very early infection, within 
10-15 days of exposure, before antibody tests are able to detect HIV. 
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HIV Testing Progress and 
Challenges
While HIV testing rates have steadily increased, more than half 
of Americans still have not been tested for HIV in their lifetime.6
Lack of access to healthcare, fear, and misperceptions about 
HIV risk and the testing process itself are key barriers to 
increasing HIV testing. In addition, some healthcare settings 
have not yet made HIV testing a routine part of medical care.
Testing rates remain far too low even among groups at high 
risk for HIV, including men who have sex with men (MSM), 
African Americans, and youth. 
n  In a study of MSM in 21 U.S. cities, 44 percent of MSM 
infected with HIV were unaware of their infection.  Of 
those, 55 percent had not been tested in the past 12 months, as CDC recommends.7 
n  Although African Americans are more likely to get tested for HIV than Latinos or whites, more than a third have never 
been tested.8
n Half of high school students r eport having had sex, but CDC data show that only 13 percent have ever been tested for HIV.9 
Working to Increase HIV Testing and Linkage to Care
HIV testing is a core part of CDC’s commitment to High-Impact Prevention – a new approach to HIV prevention that aims 
to achieve a higher level of impact on the epidemic with every federal prevention dollar spent (see “The Future of HIV 
Prevention”). It is also a key element of the National HIV/AIDS Strategy, which seeks to ensure that 90 percent of Americans 
with HIV are aware of their status and that more people are linked to care within three months of their diagnosis.
CDC is working to increase testing on many fronts—in both healthcare settings and diverse community venues. For example:
n  Providing funding for health departments to implement CDC’s routine testing recommendations and provide free or 
low-cost testing in other settings
n  Piloting HIV testing programs in urban and rural pharmacies
n  Guiding individuals to nearby testing sites through HIVtest.cdc.gov   
n  Launching new phases of the Act Against AIDS campaign to increase testing in targeted populations, and supporting 
the Greater than AIDS public awareness and information campaign.  Recent CDC campaigns include:
 n HIV Screening . Standard Care: to encourage primary care providers to test patients
 n T esting Makes Us Stronger: designed for black MSM
 n T ake Charge. Take the Test: designed for African American women
 n Reasons/Razones: designed for Latino MSM
If you are a member of the news media and need more information, please visit www.cdc.gov/nchhstp/Newsroom   
or contact the News Media Line at CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention  
(404-639-8895 or NCHHSTPMediaTeam@cdc.gov).
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